Myovant/Pfizer's Relugolix Combo Therapy Shows Sustained Clinical Benefit In Uterine FibroidsBenzinga • 03/24/21
Hong Kong Suspends Pfizer/BioNTech COVID-19 Shots On Loose Caps, Minor Dirt: ReportBenzinga • 03/24/21
Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2Business Wire • 03/23/21
Pfizer Invites Public to View and Listen to Webcast of Pfizer May 4 Conference Call with AnalystsBusiness Wire • 03/23/21
These 15 Words From Pfizer's CFO Could Translate to Billions in Sales for Its COVID VaccineThe Motley Fool • 03/23/21
Pfizer/Eli Lilly's Tanezumab Safety Profile Fails To Impress FDA Even After 15 Years Of Development Across 41 TrialsBenzinga • 03/22/21